Celine Valery
Adjunct Associate Professor
Details
-
College: School of Health and Biomedical Sciences
-
Department: Health and Biomedical Sciences
-
Campus: City Campus Australia
-
celine.valery@rmit.edu.au
-
ORCID: 0000-0003-4724-3651
-
LinkedIn
Open to
- Masters Research or PhD student supervision
- Industry Projects
- Collaborative projects
- Media enquiries
- Join a web conference as a panellist or speaker
About
Senior lecturer, Program manager and Lab Head (Pharmaceutical Science)
Currently head of the NanoBioPharm Lab and Senior Lecturer/Program manager of pharmaceutical science at RMIT University (Melbourne, Australia), I started my career as a researcher in drug delivery for the pharmaceutical industry, before returning to academia for the love of basic science and education. My initial background is in chemical engineering (MSc), physical chemistry (MSc) and pharmacy (PhD).
As key achievements, I have contributed to the FDA and EMA approvals of Somatuline Autogel (Ipsen), a nanostructured peptide hydrogel providing 1-month sustained release therapy. I have now established my research group - the NanoBioPharm lab - with a clear vision, sustainable funding and efficient operation. We are now a thriving team of about 10 researchers, at all levels of experience, succeeding in peptide/protein drug discovery, pre-clinical development and industry translation; we are also developing new peptide nano-composite materials, including metal-organic nanostructured aerogels and nano/micro-needles.
Currently head of the NanoBioPharm Lab and Senior Lecturer/Program manager of pharmaceutical science at RMIT University (Melbourne, Australia), I started my career as a researcher in drug delivery for the pharmaceutical industry, before returning to academia for the love of basic science and education. My initial background is in chemical engineering (MSc), physical chemistry (MSc) and pharmacy (PhD).
As key achievements, I have contributed to the FDA and EMA approvals of Somatuline Autogel (Ipsen), a nanostructured peptide hydrogel providing 1-month sustained release therapy. I have now established my research group - the NanoBioPharm lab - with a clear vision, sustainable funding and efficient operation. We are now a thriving team of about 10 researchers, at all levels of experience, succeeding in peptide/protein drug discovery, pre-clinical development and industry translation; we are also developing new peptide nano-composite materials, including metal-organic nanostructured aerogels and nano/micro-needles.
Media
UN sustainable development goals
- 3 Good Health and Well Being
- 5 Gender Equality
- 9 Industry, Innovation and Infrastructure
- 17 Partnerships for the Goals
- 13 Climate Action
Supervisor projects
- Structural Characterisation of Protein Aggregates in Biopharmaceutical Formulations.
- 23 Feb 2023
- Rational design of biopharmaceutical formulations
- 17 Feb 2023
- Investigation of DNA-targeted nanoformulations for diagnostic imaging and therapy
- 19 Jul 2022
- Peptide templated synthesis of composite materials: physicochemical mechanisms and nanotechnology applications
- 17 Feb 2022
- The Mechanistic Role of Alpha-synuclein Hyperphosphorylation in Parkinson’s Disease Pathogenicity
- 24 Oct 2019
- Optimisation of Preparatory Conditions for Cryogenic Scanning Electron Microscopy of Peptide Hydrogels
- 7 Aug 2019
- Ultrashort Self-Assembling Peptides As Antimicrobial Agents: Structure-Function Relationships and Applications
- 2 Jul 2018
- Extended-release formulations of somatostatin for ocular application and their effect on vascular endothelial growth factor as a biomarker of diabetic retinopathy
- 22 Mar 2017
- Biomimetic Lipidic Self-Assembly Materials for Encapsulation and Controlled Release of Protein Therapeutics.
- 29 Feb 2016
- Interactions of neuropeptide functional amyloids with biomolecules: insights into biological relevance and potential as biomaterials
- 28 Aug 2015
- Histidine Protonation as a Possible Mechanism for Human Transthyretin Amyloidosis: Modelled Against Wallaby Transthyretin
- 1 Mar 2013
Teaching interests
Teaching: Pharmacology, Drug discovery and development, Drug regulations.
Program management: Bachelor and Honours of Pharmaceutical Science.
Program management: Bachelor and Honours of Pharmaceutical Science.
Research interests
Peptide and protein therapeutics, Peptide self-assembly, Protein aggregation, Nanostructure, Bionanotechnology, Pharmaceutical formulation, Biophysics.
